Bausch Health
BHC
#4263
Rank
โ‚น227.06 B
Marketcap
โ‚น612.11
Share price
0.29%
Change (1 day)
-13.32%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น87.06. In 2024 the company made an earnings per share (EPS) of -โ‚น10.77 an increase over its 2023 EPS that were of -โ‚น145.40.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-886.43%
2024-โ‚น10.77-92.59%
2023-โ‚น145.40160.89%
2022-โ‚น55.73-76.64%
2021-โ‚น238.5668.45%
2020-โ‚น141.62-68.91%
2019-โ‚น455.49-57.11%
2018-โ‚น1,062-272.22%
2017โ‚น616.70-199.29%
2016-โ‚น621.08798.7%
2015-โ‚น69.11-128.31%
2014โ‚น244.13-204.62%
2013-โ‚น233.36602.7%
2012-โ‚น33.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น85.26-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น21.54-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA